In recent studies, enhanced activities of acid sphingomyelinase (ASM) and increased ceramide production have been shown to play a pivotal role in mediating podocyte injury and glomerulosclerosis during hyperhomocysteinemia and obesity [31–33]. This evidence concerns the gene SMPD1 and Obesity.